
Eloxx Pharmaceuticals rose 12749900.0% from $0.00 to $12.75, ahead of the S&P 500's +13.4%. Its worst day was Dec 2 (−99.0%), and its low came Dec 2 at $0.00.
Nov 20, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Eloxx Pharmaceuticals closed at its lowest level of the year, 99.0% below where the year started.
−99.0%, the year's worst day
Eloxx Pharmaceuticals shares rose 99900.0%, while the S&P 500 fell 1.4%.
Story events cover the past 12 months · Times ET
+99900.0%, the year's best day · S&P 500 −1.4%
EPS of $-0.66 was reported on $0.00 revenue.
−4.8% · S&P 500 +0.3%
Eloxx Pharmaceuticals closed at its highest level of the year, 20974900.0% above where the year started.
+16.3% · S&P 500 +0.4%
EPS of $-0.49 beat the $-0.58 estimate on $0.00 revenue.
−3.0% · S&P 500 −1.9%
Where it ended: a close of $12.75 on Nov 16, 2026. Up next: Q3 2026 earnings on Nov 16, 2026 (EPS est. $-0.58).
Nothing in the past 12 months.
All ELOX dividend historyReplay the year: the line draws itself and stops at each of the 5 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ELOX and SPY from Benzinga historical bars. Not investment advice.